Brief: Titan Pharmaceuticals Says Nasdaq Notified That Co No Longer In Compliance With Listing Rules
08/01/2021 21:38
Jan 8 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS INC - ON JAN 4, 2021 RECEIVED
LETTER FROM
NASDAQ NOTIFYING THAT CO IS NO LONGER IN COMPLIANCE WITH NASDAQ
LISTING RULES
* TITAN PHARMACEUTICALS INC - NASDAQ HAS PROVIDED CO WITH 45
CALENDAR DAYS TO SUBMIT PLAN TO REGAIN COMPLIANCE WITH ANNUAL
MEETING REQUIREMENT
* TITAN PHARMACEUTICALS INC - HELD ANNUAL MEETING ON JAN 8,
2021
AND BELIEVES IT HAS REGAINED COMPLIANCE WITH NASDAQ REQUIREMENT
FOR CONTINUED LISTING
Source text: (https://bit.ly/2XlouYE)
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.